Eli Lilly (LLY) will acquire Verve Therapeutics (VERV) for up to $13.5/share, aiming to revolutionize cholesterol treatment.

Most importantly, don’t leave nutrition and exercise out of the equation. There is a huge difference between a healthy and an unhealthy thin person.

(Reuters) -Telehealth firm 9amHealth has partnered with billionaire entrepreneur Mark Cuban's Cost Plus Drug Company to offer ...

Fact checked by Nick Blackmer Wegovy, Zepbound, and other glucagon-like peptide-1 (GLP-1) drugs saw incredible success in clinical trials for weight loss and have since become hugely popular across ...